Author: admin

ViiV Healthcare Announces the designation of priority review for dolutegravir as a potential treatment for HIV infection. London, United Kingdom, February 2013.- ViiV Healthcare has announced that the. Food and Drug Administration (FDA) of the United States has granted the designation of priority review to dolutegravir for the treatment of HIV infection, in combination with other antiretroviral agents, in adults and adolescents. The priority review designation is assigned to which, if adopted, have the potential to provide a significant benefit compared to marketed drugs or drugs that provides a treatment where there is no adequate therapies. The FDA has set the deadline to complete the review of dolutegravir on August 17, 2013, within the program Prescription Drug User Fee Act (PDUFA). As dolutegravir new drug application was submitted to the FDA on December 17, 2012, and includes the results of four clinical pivotal trials in which a total of 2.553 patients have been treated with HIV/AIDS in all stages of treatment, from patients who have not received anti-retroviral treatment to patients in failure. Dolutegravir is in development and subject to the evaluation of their benefits and risks by regulators before it can be approved and may be available for prescription. ViiV Healthcare submitted a marketing authorization application for dolutegravir at the European Medicines Agency (EMA) on 17 December of 2012. About ViiV Healthcare ViiV Healthcare is a global company...

Mediformplus free your heart of cholesterol ”: March campaign. -Mediformplus presents the Plan of campaign for the month of March with the aim of pharmacy help attract clients/patients through the pharmaceutical Council as a distinguishing value – free your heart of cholesterol ” is the campaign for the month of Cardiovascular Health in the Pharmacy, will feature different pieces of communication -boost Plan loyalty and attract new customers are some of the objectives of this campaign Madrid, 2013-February Mediformplus, Spanish leader in the management consulting and Strategic Marketing for the pharmacy, proposes a new campaign for the month of Marchfocusing on Cardiovascular Health in the pharmacy. Free your heart of cholesterol ” aims to capture and customer loyalty and increasing sales through the pharmaceutical Council as a differentiating value. To carry out this plan, the Pharmacy has different communication elements such as banners, brochures, posters for the showcase or the counter. Thus guide the customer / patient from the outside to the pharmacy counter where you will receive a Council by the pharmacist, the distinctive value of the pharmacy with respect to other clients. In addition, this campaign has customizable parts of communication with the image of the card, thus inviting our customers to use in their purchases of Parapharmacy products. A campaign plan that helps boost the Pharmacy and achieve greater profitability, because as Lewis Carroll said can...

Specialised training in Pulmonology, key in achieving clinical excellence practice. laboratories Chiesi organizes the “5th meeting for residents (R3): present and future in pneumology ” backed by the Spanish society of Pneumology and thoracic surgery (SEPAR).“ – more than 100 residents of Pneumology has brought together these days, Santiago de Compostela, in order to review the basics of the neumologica clinic from a practical point of view -the importance of holding such meetings is crucial to the future pulmonologists may deepen their scientific knowledge -the future of the Pneumology will mean a change in the form of exercise it. The pulmonologist should bring to the hospital value added that it must be reflected in excellence of the acute and chronic patient care, avoiding hospitalizations and improving outpatient care Santiago de Compostela, February 2013.- with the aim of contributing to the formation of the residents of Pneumology, pharmaceutical Chiesi Spain and the Spanish society of Pneumology and thoracic surgery (SEPAR) have organized the “5th meeting for residents (R3): present and future in pneumology” directed to complete the preparation of this professional group. The scientific coordination of the meeting has been in charge of the SEPAR. For Dr. Luis Perez of the plain, Coordinator of the meeting specialised training in Pulmonology, at the present time, must allow that the newly-formed lung specialists should be able to make a practice of excellence...